SCHEMBL994874

SCHEMBL994874

CC1(C)COC(C)(c2ccc([Mg]Br)cc2)OC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1934134 0.86 TSHR (0.36) —
SCHEMBL3995603 0.79 TAAR1 (0.43) —
SCHEMBL3996025 0.74 TRPA1 (0.32) —
SCHEMBL873359 0.74 CHRNB2 (0.41) —
SCHEMBL13808489 0.70 KCNH2 (0.31) —
SCHEMBL993356 0.69 SMN1; SMN2 (0.50) —
SCHEMBL3588207 0.68 HCAR3 (0.36) —
SCHEMBL13909297 0.67 CPT1B (0.41) —
SCHEMBL11737432 0.66 PGR (0.33) —
SCHEMBL587682 0.66 TAAR1 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206219-B2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-12-08 — — US disclosed
US-20120258941-A1 17-HYDROXY-17-PENTAFLUORETHYL-ESTRA-4,9(10)-DIEN-11-ARYL DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND THE USE THEREOF FOR TREATING DISEASES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-10-11 — — US disclosed
EP-2456780-A2 17-HYDROXY-17-PENTAFLUORETHYL-ESTRA-4,9(10)-DIEN-11-ARYL DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND THE USE THEREOF FOR TREATING DISEASES Bayer Pharma Aktiengesellschaft (DE) 2012-05-30 — — EP disclosed
WO-2011009534-A2 17-HYDROXY-17-PENTAFLUORETHYL-ESTRA-4,9(10)-DIEN-11-ARYL DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND THE USE THEREOF FOR TREATING DISEASES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-01-27 — — WO disclosed
EP-0422100-B1 11 BETA-SUBSTITUTED PROGESTERONE ANALOGS RES TRIANGLE INST (US) 1997-03-12 — — EP disclosed
EP-0422100-A4 — — 1994-04-27 — — EP disclosed
US-5073548-A Antiprogestational, progestational and antiglucocorticoid activity; glandular disorders; vision defects; antifertility agents RESEARCH TRIANGLE INSTITUTE (US) 1991-12-17 — — US disclosed
EP-0422100-A1 11-g(b)-SUBSTITUTED PROGESTERONE ANALOGS. RES TRIANGLE INST (US) 1991-04-17 — — EP disclosed
US-4954490-A HORMONE INHIBITORS RESEARCH TRIANGLE INSTITUTE (US) 1990-09-04 — — US disclosed
WO-1989012448-A1 11beta-SUBSTITUTED PROGESTERONE ANALOGS RESEARCH TRIANGLE INSTITUTE (US) 1989-12-28 — — WO disclosed
Send feedback